My area of academic pursuit is the treatment of hematologic malignancies and hematopoietic stem cell transplantation. I serve on the Core Transplant, Myeloma and Leukemia Committees of the CALGB, the Myeloma Committee of the BMT Clinical Trials Network (CTN) and the Cancer Education Committee of the American Society of Clinical Oncology (ASCO). I also serve on the Steering and Project Review of the Multiple Myeloma Research Consortium (MMRC). I have served as the principal investigator on several national and institutional clinical trials looking at strategies to improve the outcome of patients with multiple myeloma, acute myeloid leukemia and myelodysplastic syndromes.
As Chair of the Development Program Advisory Panel for the Center for Multiple Myeloma Nanotechnology at Washington University and as the Principal Investigator for the Multiple Myeloma Tissue Banking initiative, I am working closely with basic scientists both within and outside the institution to study the genomics and biology of the disease and harness the knowledge to foster better therapeutic options for multiple myeloma to foster an era of personalized and precision medicine.